Malamba-Banda, Chikondi
Mhango, Chimwemwe
Benedicto-Matambo, Prisca
Mandolo, Jonathan J.
Chinyama, End
Kumwenda, Orpha
Barnes, Kayla G.
Cunliffe, Nigel A.
Iturriza-Gomara, Miren
Jambo, Kondwani C.
Jere, Khuzwayo C.
Funding for this research was provided by:
Wellcome (201945/Z/16/Z)
Bill and Melinda Gates Foundation (OPP1180423, INV-046917, INV-046917)
NIH Fogarty Fellowship (K01TW010853)
World Health Organization (2018/815189-0)
Article History
Received: 7 November 2022
Accepted: 22 May 2023
First Online: 2 June 2023
Competing interests
: M.I.-G. has received investigator-initiated research grant support from the GSK group of companies and Sanofi Pasteur Merck Sharpe & Dohme and Merck. N.A.C. has received investigator-initiated grant support for rotavirus research and honoraria for participation in DSMB rotavirus vaccine meetings from the GSK group of companies and honoraria from Sanofi Pasteur for rotavirus vaccine advisory board. K.C.J.2 has received investigator-initiated research grant support from the GSK group of companies. C.M.B., C.M., P.B.M., J.J.M., O.K., K.G.B., K.C.J.1 and E.C. declare no competing interests.